1 completed, 1 terminated, 1 withdrawn. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 2 | Terminated 1, Withdrawn 1 |
Follow combretastatin: new trials by email Literature Review of combretastatin trials Research Report on combretastatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fosbretabulin or Placebo in Combination With Carboplatin/Paclitaxel in Anaplastic Thyroid Cancer Fosbretabulin + paclitaxel + carboplatin, Placebo + paclitaxel + carboplatin - Anaplastic Thyroid Cancer | Phase 3 | Withdrawn | Mateon Therapeutics | 2015-03-01 | 2014-05-01 | |
| Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV) fosbretabulin, Saline - Polypoidal Choroidal Vasculopathy | Phase 2 | Completed | Mateon Therapeutics | 20 | 2009-07-01 | 2011-11-01 |
| Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer CA4P, paclitaxel, carboplatin - Anaplastic Thyroid Cancer | Phase 2 / Phase 3 | Terminated | Mateon Therapeutics | 80 | 2007-08-01 | 2014-06-09 |
Thyroid Carcinoma, Anaplastic (2) · Thyroid Neoplasms (2) · Head and Neck Neoplasms (1) · Polypoidal Choroidal Vasculopathy (1)
United States (2) · Belarus (1) · Bulgaria (1) · Egypt (1) · Hong Kong (1) · India (1) · Israel (1) · Italy (1) · Poland (1) · Romania (1) · Russia (1) · Singapore (1) · South Korea (1) · Taiwan (1) · Ukraine (1)
Julie A Sosa, MD (1) · Julie A. Sosa, MD, FACS (1) · Lisa Licitra, MD (1) · Marcia Brose, MD, PhD (1)